GET /api/v0.1/hansard/entries/1341052/?format=api
HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"id": 1341052,
"url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1341052/?format=api",
"text_counter": 322,
"type": "speech",
"speaker_name": "Dr Susan Nakhumicha",
"speaker_title": "The Cabinet Secretary for Health",
"speaker": null,
"content": " Thank you, Hon. Temporary Speaker and Hon. Members. On the issue of availability of anti-epileptic drugs, I would like to answer it together and generally in terms of availability of all drugs at health facilities. We have had challenges in our supply chain. We have had challenges in our key institution, Kenya Medical Supplies Agency (KEMSA), in terms of being able to meet all the essential drugs and supplies to avail them to the country. Our fill rate has been very low, reason being that we have never received payments in time from the county governments whenever they ordered for supplies. Equally, we have a dead stock of COVID-19 supplies that we are struggling with. We have had a conversation with the Executive Office of the President, and we are in the process of recapitalising KEMSA with Ksh2 billion to ensure that it buys the essential medical supplies so that we can get 100 per cent fill rate for all the essential supplies that are ordered by the counties. On the issue of local manufacturing, the Hon. Member asked by what time. We are already implementing this. In the ongoing tender at KEMSA, 50 per cent of the tender was The electronic version of the Official Hansard Report is for information purposesonly. A certified version of this Report can be obtained from the Hansard Editor."
}